These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 12684540)

  • 1. Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene.
    Korth C; Kaneko K; Groth D; Heye N; Telling G; Mastrianni J; Parchi P; Gambetti P; Will R; Ironside J; Heinrich C; Tremblay P; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4784-9. PubMed ID: 12684540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A traceback phenomenon can reveal the origin of prion infection.
    Kobayashi A; Asano M; Mohri S; Kitamoto T
    Neuropathology; 2009 Oct; 29(5):619-24. PubMed ID: 19659941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse-adapted sporadic human Creutzfeldt-Jakob disease prions propagate in cell culture.
    Lawson VA; Vella LJ; Stewart JD; Sharples RA; Klemm H; Machalek DM; Masters CL; Cappai R; Collins SJ; Hill AF
    Int J Biochem Cell Biol; 2008; 40(12):2793-801. PubMed ID: 18590830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human prion strain selection in transgenic mice.
    Giles K; Glidden DV; Patel S; Korth C; Groth D; Lemus A; DeArmond SJ; Prusiner SB
    Ann Neurol; 2010 Aug; 68(2):151-61. PubMed ID: 20695008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion protein transgenes and the neuropathology in prion diseases.
    DeArmond SJ; Prusiner SB
    Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology and genetics of prion diseases.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein.
    Telling GC; Scott M; Hsiao KK; Foster D; Yang SL; Torchia M; Sidle KC; Collinge J; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9936-40. PubMed ID: 7937921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular dendritic cell of the knock-in mouse provides a new bioassay for human prions.
    Kitamoto T; Mohri S; Ironside JW; Miyoshi I; Tanaka T; Kitamoto N; Itohara S; Kasai N; Katsuki M; Higuchi J; Muramoto T; Shin RW
    Biochem Biophys Res Commun; 2002 Jun; 294(2):280-6. PubMed ID: 12051707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant-negative inhibition of prion replication in transgenic mice.
    Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of Creutzfeldt-Jakob disease prion propagation by the A224V mutation.
    Watts JC; Giles K; Serban A; Patel S; Oehler A; Bhardwaj S; Guan S; Greicius MD; Miller BL; DeArmond SJ; Geschwind MD; Prusiner SB
    Ann Neurol; 2015 Oct; 78(4):540-53. PubMed ID: 26094969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions.
    Taguchi Y; Mohri S; Ironside JW; Muramoto T; Kitamoto T
    Am J Pathol; 2003 Dec; 163(6):2585-93. PubMed ID: 14633630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins.
    Asante EA; Gowland I; Grimshaw A; Linehan JM; Smidak M; Houghton R; Osiguwa O; Tomlinson A; Joiner S; Brandner S; Wadsworth JDF; Collinge J
    J Gen Virol; 2009 Mar; 90(Pt 3):546-558. PubMed ID: 19218199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology and transgenetics of prion diseases.
    Prusiner SB
    Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prions in skeletal muscle.
    Bosque PJ; Ryou C; Telling G; Peretz D; Legname G; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3812-7. PubMed ID: 11904434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic models of prion disease.
    Scott MR; Supattapone S; Nguyen HO; DeArmond SJ; Prusiner SB
    Arch Virol Suppl; 2000; (16):113-24. PubMed ID: 11214913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic mammalian prions.
    Legname G; Baskakov IV; Nguyen HO; Riesner D; Cohen FE; DeArmond SJ; Prusiner SB
    Science; 2004 Jul; 305(5684):673-6. PubMed ID: 15286374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into prion strains and neurotoxicity.
    Aguzzi A; Heikenwalder M; Polymenidou M
    Nat Rev Mol Cell Biol; 2007 Jul; 8(7):552-61. PubMed ID: 17585315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.